SCHEMBL96919

SCHEMBL96919

CCN(C)CCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12296158 0.95 PIK3CD (0.50)
SCHEMBL17643406 0.85 PIK3CD (0.41)
SCHEMBL259497 0.84 PIK3CD (0.62)
SCHEMBL6487126 0.83
Hydrochloric Acid SCHEMBL4659475 0.81 PIK3CD (0.59)
SCHEMBL13510912 0.81 PIK3CD (0.39)
SCHEMBL735129 0.80
SCHEMBL13907566 0.79 PIK3CD (0.37)
SCHEMBL13554187 0.79 PIK3CD (0.46)
SCHEMBL15618888 0.79 CHRNB2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110058428-A A kind of two-sided active infrared emissivity adjusts film and its preparation method and application 中国空间技术研究院 2019-07-26 CN claimed
CN-109752077-A A kind of vibrational state visual detection device, production method and application 吉林大学 2019-05-14 CN claimed
WO-2012048411-A1 PLK-4 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME UNIVERSITY HEALTH NETWORK (CA) 2012-04-19 WO claimed
US-7897778-B2 Benzamide compounds ASTRAZENECA (SE) 2011-03-01 US claimed
US-20080293687-A1 Benzamide Compounds ASTRAZENECA AB (SE) 2008-11-27 US claimed
WO-2006024841-A2 BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-03-09 WO claimed
US-4238206-A TERTIARY AMINE OR CARBONATE SOLVENT COLUMBIA GAS SYSTEM SERVICE CORPORATION (US) 1980-12-09 US claimed
EP-4720046-A1 SULFONAMIDE COMPOUNDS AS CAV2.3 ANTAGONISTS Lario Therapeutics Limited (GB) 2026-04-08 EP disclosed
WO-2024246524-A1 SULFONAMIDE COMPOUNDS AS CAV2.3 ANTAGONISTS LARIO THERAPEUTICS LIMITED (GB) 2024-12-05 WO disclosed
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 US disclosed
US-20240229063-A1 TRANSGENIC CORN EVENT ZM_CSM63715 AND METHODS FOR DETECTION AND USES THEREOF MONSANTO TECHNOLOGY LLC (US) 2024-07-11 US disclosed
CN-117813334-A Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same 广荣化学株式会社 2024-04-02 CN disclosed
WO-2024058921-A2 IMPROVED IONOMER BLENDS, HIGH-TEMPERATURE POLYMER ELECTROLYTE MEMBRANES AND ELECTRODE ASSEMBLIES THE PENN STATE RESEARCH FOUNDATION (US) 2024-03-21 WO disclosed
WO-2005113003-A2 METHOD FOR AUGMENTING B CELL DEPLETION GENENTECH, INC. (US) 2005-12-01 WO disclosed
WO-2004096226-A1 QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2004-11-11 WO disclosed
EP-0501693-B1 Isoquinoline derivatives BANYU PHARMA CO LTD (JP) 1996-08-28 EP disclosed
US-5362736-A Alkoxy derivatives for cardiovascular disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-11-08 US disclosed
WO-1994007869-A1 QUINAZOLINE DERIVATIVES ZENECA LIMITED (GB) 1994-04-14 WO disclosed
EP-0501693-A1 Isoquinoline derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1992-09-02 EP disclosed
US-4238206-A TERTIARY AMINE OR CARBONATE SOLVENT COLUMBIA GAS SYSTEM SERVICE CORPORATION (US) 1980-12-09 US disclosed